{"entity":{"type":"insider","cik":"0001610876","url":"/insider/0001610876","json_url":"/insider/0001610876.json","name":"Chodakewitz Jeffrey","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":90,"n_filings":29,"first":"2014-10-09","last":"2018-02-14","span_basis":"filed_date"},"name_variants":[{"name":"Chodakewitz Jeffrey","source":"filing","n_filings":29,"first_seen":"2014-10-09","last_seen":"2018-02-14"}],"transactions":[{"id":6356412,"accession":"0001209191-18-010119","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-010119","line_url":"/filing/0001209191-18-010119#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2022.0,"shares_display":"2,022","price_per_share":151.26,"price_display":"151.26","price_state":"stated","total_value":305847.72,"total_display":"305,847.72","shares_owned_after":70363.0,"shares_owned_after_display":"70,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-14","scope":"insider"},{"id":6356409,"accession":"0001209191-18-010119","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-010119","line_url":"/filing/0001209191-18-010119#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":149.21,"price_display":"149.21","price_state":"stated","total_value":193973.0,"total_display":"193,973.00","shares_owned_after":73485.0,"shares_owned_after_display":"73,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-14","scope":"insider"},{"id":6356406,"accession":"0001209191-18-010119","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-010119","line_url":"/filing/0001209191-18-010119#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":150.47,"price_display":"150.47","price_state":"stated","total_value":165517.0,"total_display":"165,517.00","shares_owned_after":72385.0,"shares_owned_after_display":"72,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-14","scope":"insider"},{"id":6356404,"accession":"0001209191-18-010119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-010119","line_url":"/filing/0001209191-18-010119#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":152.62,"price_display":"152.62","price_state":"stated","total_value":61048.0,"total_display":"61,048.00","shares_owned_after":69963.0,"shares_owned_after_display":"69,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-14","scope":"insider"},{"id":6356401,"accession":"0001209191-18-010119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-010119","line_url":"/filing/0001209191-18-010119#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":153.69,"price_display":"153.69","price_state":"stated","total_value":46107.0,"total_display":"46,107.00","shares_owned_after":69663.0,"shares_owned_after_display":"69,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-14","scope":"insider"},{"id":6257403,"accession":"0001209191-18-008224","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-008224","line_url":"/filing/0001209191-18-008224#line-8","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":164.12,"price_display":"164.12","price_state":"stated","total_value":147708.0,"total_display":"147,708.00","shares_owned_after":52624.0,"shares_owned_after_display":"52,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6257400,"accession":"0001209191-18-008224","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-18-008224","line_url":"/filing/0001209191-18-008224#line-7","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":159.62,"price_display":"159.62","price_state":"stated","total_value":111734.0,"total_display":"111,734.00","shares_owned_after":54924.0,"shares_owned_after_display":"54,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6257397,"accession":"0001209191-18-008224","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-008224","line_url":"/filing/0001209191-18-008224#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":161.51,"price_display":"161.51","price_state":"stated","total_value":80755.0,"total_display":"80,755.00","shares_owned_after":53924.0,"shares_owned_after_display":"53,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6257394,"accession":"0001209191-18-008224","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-008224","line_url":"/filing/0001209191-18-008224#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":160.5,"price_display":"160.50","price_state":"stated","total_value":80250.0,"total_display":"80,250.00","shares_owned_after":54424.0,"shares_owned_after_display":"54,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6257389,"accession":"0001209191-18-008224","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-008224","line_url":"/filing/0001209191-18-008224#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":494.0,"shares_display":"494","price_per_share":158.32,"price_display":"158.32","price_state":"stated","total_value":78210.08,"total_display":"78,210.08","shares_owned_after":55624.0,"shares_owned_after_display":"55,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6257386,"accession":"0001209191-18-008224","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-008224","line_url":"/filing/0001209191-18-008224#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":162.94,"price_display":"162.94","price_state":"stated","total_value":65176.0,"total_display":"65,176.00","shares_owned_after":53524.0,"shares_owned_after_display":"53,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6257383,"accession":"0001209191-18-008224","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-008224","line_url":"/filing/0001209191-18-008224#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":164.71,"price_display":"164.71","price_state":"stated","total_value":16471.0,"total_display":"16,471.00","shares_owned_after":52524.0,"shares_owned_after_display":"52,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6452288,"accession":"0001209191-18-007617","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-007617","line_url":"/filing/0001209191-18-007617#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":996.0,"shares_display":"996","price_per_share":166.1,"price_display":"166.10","price_state":"stated","total_value":165435.6,"total_display":"165,435.60","shares_owned_after":52724.0,"shares_owned_after_display":"52,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-02","filed_date":"2018-02-05","scope":"insider"},{"id":6452285,"accession":"0001209191-18-007617","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-007617","line_url":"/filing/0001209191-18-007617#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":165.23,"price_display":"165.23","price_state":"stated","total_value":99138.0,"total_display":"99,138.00","shares_owned_after":53720.0,"shares_owned_after_display":"53,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-02","filed_date":"2018-02-05","scope":"insider"},{"id":6452281,"accession":"0001209191-18-007617","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-007617","line_url":"/filing/0001209191-18-007617#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":169.49,"price_display":"169.49","price_state":"stated","total_value":16949.0,"total_display":"16,949.00","shares_owned_after":52524.0,"shares_owned_after_display":"52,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-02","filed_date":"2018-02-05","scope":"insider"},{"id":6452278,"accession":"0001209191-18-007617","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-007617","line_url":"/filing/0001209191-18-007617#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":168.06,"price_display":"168.06","price_state":"stated","total_value":16806.0,"total_display":"16,806.00","shares_owned_after":52624.0,"shares_owned_after_display":"52,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-02","filed_date":"2018-02-05","scope":"insider"},{"id":6452267,"accession":"0001209191-18-007617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-007617","line_url":"/filing/0001209191-18-007617#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":167.44,"price_display":"167.44","price_state":"stated","total_value":318136.0,"total_display":"318,136.00","shares_owned_after":52524.0,"shares_owned_after_display":"52,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-05","scope":"insider"},{"id":6041764,"accession":"0001209191-18-003958","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-003958","line_url":"/filing/0001209191-18-003958#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":157.54,"price_display":"157.54","price_state":"stated","total_value":141786.0,"total_display":"141,786.00","shares_owned_after":54724.0,"shares_owned_after_display":"54,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-17","scope":"insider"},{"id":6041762,"accession":"0001209191-18-003958","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-003958","line_url":"/filing/0001209191-18-003958#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":519.0,"shares_display":"519","price_per_share":155.8,"price_display":"155.80","price_state":"stated","total_value":80860.2,"total_display":"80,860.20","shares_owned_after":55624.0,"shares_owned_after_display":"55,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-17","scope":"insider"},{"id":6041759,"accession":"0001209191-18-003958","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-003958","line_url":"/filing/0001209191-18-003958#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":159.04,"price_display":"159.04","price_state":"stated","total_value":47712.0,"total_display":"47,712.00","shares_owned_after":54424.0,"shares_owned_after_display":"54,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-17","scope":"insider"},{"id":6853576,"accession":"0001209191-18-001000","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-001000","line_url":"/filing/0001209191-18-001000#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":152.06,"price_display":"152.06","price_state":"stated","total_value":243296.0,"total_display":"243,296.00","shares_owned_after":55287.0,"shares_owned_after_display":"55,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-03","scope":"insider"},{"id":6853572,"accession":"0001209191-18-001000","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-001000","line_url":"/filing/0001209191-18-001000#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":863.0,"shares_display":"863","price_per_share":152.8,"price_display":"152.80","price_state":"stated","total_value":131866.4,"total_display":"131,866.40","shares_owned_after":54424.0,"shares_owned_after_display":"54,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-03","scope":"insider"},{"id":6853566,"accession":"0001209191-18-001000","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-001000","line_url":"/filing/0001209191-18-001000#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":675.0,"shares_display":"675","price_per_share":150.87,"price_display":"150.87","price_state":"stated","total_value":101837.25,"total_display":"101,837.25","shares_owned_after":56887.0,"shares_owned_after_display":"56,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-03","scope":"insider"},{"id":6853561,"accession":"0001209191-18-001000","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-001000","line_url":"/filing/0001209191-18-001000#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":149.65,"price_display":"149.65","price_state":"stated","total_value":44895.0,"total_display":"44,895.00","shares_owned_after":57562.0,"shares_owned_after_display":"57,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-03","scope":"insider"},{"id":4630917,"accession":"0001209191-17-059474","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-059474","line_url":"/filing/0001209191-17-059474#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3594.0,"shares_display":"3,594","price_per_share":144.69,"price_display":"144.69","price_state":"stated","total_value":520015.86,"total_display":"520,015.86","shares_owned_after":54424.0,"shares_owned_after_display":"54,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-03","filed_date":"2017-11-06","scope":"insider"},{"id":4630899,"accession":"0001209191-17-059474","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-059474","line_url":"/filing/0001209191-17-059474#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1096.0,"shares_display":"1,096","price_per_share":144.89,"price_display":"144.89","price_state":"stated","total_value":158799.44,"total_display":"158,799.44","shares_owned_after":54724.0,"shares_owned_after_display":"54,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-06","scope":"insider"},{"id":4630895,"accession":"0001209191-17-059474","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-059474","line_url":"/filing/0001209191-17-059474#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":143.54,"price_display":"143.54","price_state":"stated","total_value":57416.0,"total_display":"57,416.00","shares_owned_after":55820.0,"shares_owned_after_display":"55,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-06","scope":"insider"},{"id":4630890,"accession":"0001209191-17-059474","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-059474","line_url":"/filing/0001209191-17-059474#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":145.89,"price_display":"145.89","price_state":"stated","total_value":43767.0,"total_display":"43,767.00","shares_owned_after":54424.0,"shares_owned_after_display":"54,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-06","scope":"insider"},{"id":5038664,"accession":"0001209191-17-058479","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-17-058479","line_url":"/filing/0001209191-17-058479#line-8","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25784.0,"shares_display":"25,784","price_per_share":144.46,"price_display":"144.46","price_state":"stated","total_value":3724756.64,"total_display":"3,724,756.64","shares_owned_after":83140.0,"shares_owned_after_display":"83,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-10-31","scope":"insider"},{"id":5038660,"accession":"0001209191-17-058479","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-17-058479","line_url":"/filing/0001209191-17-058479#line-7","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19016.0,"shares_display":"19,016","price_per_share":145.26,"price_display":"145.26","price_state":"stated","total_value":2762264.16,"total_display":"2,762,264.16","shares_owned_after":64124.0,"shares_owned_after_display":"64,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-10-31","scope":"insider"},{"id":5038655,"accession":"0001209191-17-058479","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-058479","line_url":"/filing/0001209191-17-058479#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4700.0,"shares_display":"4,700","price_per_share":146.52,"price_display":"146.52","price_state":"stated","total_value":688644.0,"total_display":"688,644.00","shares_owned_after":59424.0,"shares_owned_after_display":"59,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-10-31","scope":"insider"},{"id":5038646,"accession":"0001209191-17-058479","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-058479","line_url":"/filing/0001209191-17-058479#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":143.46,"price_display":"143.46","price_state":"stated","total_value":588186.0,"total_display":"588,186.00","shares_owned_after":108924.0,"shares_owned_after_display":"108,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-10-31","scope":"insider"},{"id":5038643,"accession":"0001209191-17-058479","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-058479","line_url":"/filing/0001209191-17-058479#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3400.0,"shares_display":"3,400","price_per_share":147.75,"price_display":"147.75","price_state":"stated","total_value":502350.0,"total_display":"502,350.00","shares_owned_after":56024.0,"shares_owned_after_display":"56,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-10-31","scope":"insider"},{"id":5038639,"accession":"0001209191-17-058479","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-058479","line_url":"/filing/0001209191-17-058479#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":148.4,"price_display":"148.40","price_state":"stated","total_value":207760.0,"total_display":"207,760.00","shares_owned_after":54624.0,"shares_owned_after_display":"54,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-10-31","scope":"insider"},{"id":5038635,"accession":"0001209191-17-058479","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-058479","line_url":"/filing/0001209191-17-058479#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":142.38,"price_display":"142.38","price_state":"stated","total_value":199332.0,"total_display":"199,332.00","shares_owned_after":113024.0,"shares_owned_after_display":"113,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-10-31","scope":"insider"},{"id":5038629,"accession":"0001209191-17-058479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-058479","line_url":"/filing/0001209191-17-058479#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":149.34,"price_display":"149.34","price_state":"stated","total_value":29868.0,"total_display":"29,868.00","shares_owned_after":54424.0,"shares_owned_after_display":"54,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-10-31","scope":"insider"},{"id":4542621,"accession":"0001209191-17-057319","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-057319","line_url":"/filing/0001209191-17-057319#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":818.0,"shares_display":"818","price_per_share":154.76,"price_display":"154.76","price_state":"stated","total_value":126593.68,"total_display":"126,593.68","shares_owned_after":115024.0,"shares_owned_after_display":"115,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-16","filed_date":"2017-10-18","scope":"insider"},{"id":4542617,"accession":"0001209191-17-057319","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-057319","line_url":"/filing/0001209191-17-057319#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":157.38,"price_display":"157.38","price_state":"stated","total_value":47214.0,"total_display":"47,214.00","shares_owned_after":114424.0,"shares_owned_after_display":"114,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-16","filed_date":"2017-10-18","scope":"insider"},{"id":4542614,"accession":"0001209191-17-057319","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-057319","line_url":"/filing/0001209191-17-057319#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":155.92,"price_display":"155.92","price_state":"stated","total_value":46776.0,"total_display":"46,776.00","shares_owned_after":114724.0,"shares_owned_after_display":"114,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-16","filed_date":"2017-10-18","scope":"insider"},{"id":4542611,"accession":"0001209191-17-057319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-057319","line_url":"/filing/0001209191-17-057319#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":153.42,"price_display":"153.42","price_state":"stated","total_value":46026.0,"total_display":"46,026.00","shares_owned_after":115842.0,"shares_owned_after_display":"115,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-16","filed_date":"2017-10-18","scope":"insider"},{"id":5320663,"accession":"0001209191-17-055918","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-055918","line_url":"/filing/0001209191-17-055918#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1443.0,"shares_display":"1,443","price_per_share":151.82,"price_display":"151.82","price_state":"stated","total_value":219076.26,"total_display":"219,076.26","shares_owned_after":115024.0,"shares_owned_after_display":"115,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":5320661,"accession":"0001209191-17-055918","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-055918","line_url":"/filing/0001209191-17-055918#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1394.0,"shares_display":"1,394","price_per_share":151.04,"price_display":"151.04","price_state":"stated","total_value":210549.76,"total_display":"210,549.76","shares_owned_after":116467.0,"shares_owned_after_display":"116,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":5320657,"accession":"0001209191-17-055918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-055918","line_url":"/filing/0001209191-17-055918#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":152.62,"price_display":"152.62","price_state":"stated","total_value":91572.0,"total_display":"91,572.00","shares_owned_after":114424.0,"shares_owned_after_display":"114,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":4417426,"accession":"0001209191-17-047716","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-17-047716","line_url":"/filing/0001209191-17-047716#line-9","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2494.0,"shares_display":"2,494","price_per_share":154.21,"price_display":"154.21","price_state":"stated","total_value":384599.74,"total_display":"384,599.74","shares_owned_after":114924.0,"shares_owned_after_display":"114,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-03","filed_date":"2017-08-04","scope":"insider"},{"id":4417422,"accession":"0001209191-17-047716","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-17-047716","line_url":"/filing/0001209191-17-047716#line-8","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":153.29,"price_display":"153.29","price_state":"stated","total_value":91974.0,"total_display":"91,974.00","shares_owned_after":117418.0,"shares_owned_after_display":"117,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-03","filed_date":"2017-08-04","scope":"insider"},{"id":4417419,"accession":"0001209191-17-047716","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-17-047716","line_url":"/filing/0001209191-17-047716#line-7","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":155.15,"price_display":"155.15","price_state":"stated","total_value":77575.0,"total_display":"77,575.00","shares_owned_after":114424.0,"shares_owned_after_display":"114,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-03","filed_date":"2017-08-04","scope":"insider"},{"id":4417402,"accession":"0001209191-17-047716","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-047716","line_url":"/filing/0001209191-17-047716#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":153.93,"price_display":"153.93","price_state":"stated","total_value":92358.0,"total_display":"92,358.00","shares_owned_after":115120.0,"shares_owned_after_display":"115,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-02","filed_date":"2017-08-04","scope":"insider"},{"id":4417396,"accession":"0001209191-17-047716","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-047716","line_url":"/filing/0001209191-17-047716#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":152.5,"price_display":"152.50","price_state":"stated","total_value":76250.0,"total_display":"76,250.00","shares_owned_after":115720.0,"shares_owned_after_display":"115,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-02","filed_date":"2017-08-04","scope":"insider"},{"id":4417393,"accession":"0001209191-17-047716","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-047716","line_url":"/filing/0001209191-17-047716#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":154.89,"price_display":"154.89","price_state":"stated","total_value":61956.0,"total_display":"61,956.00","shares_owned_after":114720.0,"shares_owned_after_display":"114,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-02","filed_date":"2017-08-04","scope":"insider"},{"id":4417389,"accession":"0001209191-17-047716","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-047716","line_url":"/filing/0001209191-17-047716#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001610876","owner_name":"Chodakewitz Jeffrey","owner_url":"/insider/0001610876","role":"Officer (EVP GMDA, CMO)","officer_title":"EVP GMDA, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":296.0,"shares_display":"296","price_per_share":156.24,"price_display":"156.24","price_state":"stated","total_value":46247.04,"total_display":"46,247.04","shares_owned_after":114424.0,"shares_owned_after_display":"114,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-02","filed_date":"2017-08-04","scope":"insider"}],"next_cursor":"2017-08-02|4417389","ledger_fault":false,"count":{"value":90,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":90,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":90},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP GMDA, CMO)","n_filings":29,"first_seen":"2014-10-09","last_seen":"2018-02-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001610876","retrieved_at":"2026-08-21T10:15:10+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}